PI Pharma Insight

MagnaPhos 97.2mg (4mmol) chewable tablets

BNF presentation 0905013G0BGABDE within chapter Nutrition and Blood. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.

Product

MagnaPhos

Chemical substance

Magnesium glycerophosphate

Presentation code

0905013G0BGABDE

Usage overview

Total items and spend derived from NHS dispensing data.

Items dispensed

259

NHS spend (£)

£8,630.22

Recent activity

March 2025

Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.

Dispensing trend

Month-by-month national usage.

Month Items dispensed
March 2025 36
December 2024 16
November 2024 47
October 2024 43
August 2024 4
July 2024 40
May 2024 5
July 2021 9
June 2021 6
December 2020 22
November 2020 31

Top pharmacies dispensing this medicine

Identify providers with the highest utilisation to focus engagement and support.

Pharmacy Items Region
Brundall Medical Partnership
ODS D82032
17 26A - NORFOLK AND WAVENEY ICB
Unknown pharmacy 16 No data available
Unknown pharmacy 7 No data available
Stanmore Medical Group
ODS E82005
6 06K - HERTFORDSHIRE AND WEST ESSEX ICB
Bishops Waltham Surgery
ODS J82064
6 D9Y0V - HAMPSHIRE AND ISLE OF WIGHT ICB
Unknown pharmacy 6 No data available
Unknown pharmacy 6 No data available
Hastings House Surgery
ODS M84030
6 B2M3M - COVENTRY AND WARWICKSHIRE ICB
Unknown pharmacy 6 No data available
North House Surgery
ODS B82008
5 42D - HUMBER AND NORTH YORKSHIRE ICB